Keros Therapeutics, Inc. (KROS): SCHEDULE 13G/A filed Oct 27, 2026

Form type

SCHEDULE 13G/A

Filing date

Oct 27, 2026

Accession number

0002052113-26-001128

Filer

Keros Therapeutics, Inc. (CIK 1664710)